Flash FinanceUS
Market closed S&P 5007,376.86+0.31% Nasdaq24,579.42+1.09% Dow 3051,285.73-0.46% Russell 20002,754.11+0.89% Nasdaq-10026,989.99+1.35% MidCap 4003,602.50+0.56% SmallCap 6001,673.98+0.05% VIX25.64-9.01% 10Y Yield4.86+0.45% Close of Nov 06, 2026
AI brief of an SEC Form 8-K · Clorox (CLX)

Clorox Q1 sales fall 19%, adjusted EPS drops 54% on ERP transition; outlook held

Negative Impact 4 of 5 earnings Written later

Clorox reported first-quarter fiscal 2026 net sales of $1.43 billion, down 19%, and diluted EPS of $0.65, down 19% from $0.80. Adjusted EPS fell 54% to $0.85, which the company attributes mainly to lower sales tied to its ERP transition. The company maintained its full-year fiscal 2026 outlook but said current expectations are toward the lower end of the range.

Key points

  • Net sales fell 19% to $1.43 billion, driven mainly by lower shipments related to the ERP transition
  • Adjusted EPS of $0.85 compared with $1.86 a year earlier; GAAP diluted EPS was $0.65 versus $0.80
  • Full-year fiscal 2026 net sales still expected to fall 6% to 10%, and diluted EPS between $5.60 and $5.95
  • Retailer inventory drawdown is expected to reduce fiscal 2026 diluted EPS by about 90 cents

The filing

CompanyClorox (CLX)
Form8-K, current report
Filed with the SECNov 3, 2025, 4:12 PM ET
Accession number0000021076-25-000051

Items reported: 2.02 Results of Operations7.01 Regulation FD Disclosure

Read the filing on SEC.gov ↗

Written by AI on Nov 8, 2026, 1:12 AM ET, from this filing only. Written later: this filing was briefed after the fact, when past filings were added to the site, so the brief may be read with hindsight; the filing itself is the record of what was known on November 03, 2025.

Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.